| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |